Issue navigation
Volume 110, Issue 7, July 2018
Solicited Editorial
Population Testing for High Penetrance Genes: Are We There Yet?
Nicolas Wentzensen and Christine D Berg
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 687–689, https://doi.org/10.1093/jnci/djx282
The Value of Helicobacter Eradication in Long-term Aspirin Users
Jack Cuzick
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 690–691, https://doi.org/10.1093/jnci/djx289
Precancerous Lesions of Ovarian Cancer—A US Perspective
Kala Visvanathan and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 692–693, https://doi.org/10.1093/jnci/djx269
Beyond Expert Opinion: Progress in the Development of Evidence-Based Screening Guidelines for Survivors of Childhood Cancer
David C Hodgson and Tara O Henderson
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 694–695, https://doi.org/10.1093/jnci/djy007
Opening the Door for Immune Oncology Studies in Invasive Lobular Breast Cancer
Steffi Oesterreich and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 696–698, https://doi.org/10.1093/jnci/djy014
Commentary
Defining Value of Cancer Therapeutics—A Health System Perspective
Christine Leopold and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 699–703, https://doi.org/10.1093/jnci/djy079
Biomarkers for Homologous Recombination Deficiency in Cancer
Michal M Hoppe and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 704–713, https://doi.org/10.1093/jnci/djy085
Articles
Cost-effectiveness of Population-Based BRCA1, BRCA2, RAD51C, RAD51D, BRIP1, PALB2 Mutation Testing in Unselected General Population Women
Ranjit Manchanda and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 714–725, https://doi.org/10.1093/jnci/djx265
Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer
Linda S Lindström and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 726–733, https://doi.org/10.1093/jnci/djx270
Smoking, Sex, and Non–Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424)
Ting-Yuan David Cheng and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 734–742, https://doi.org/10.1093/jnci/djx260
Aspirin and Risk of Gastric Cancer After Helicobacter pylori Eradication: A Territory-Wide Study
Ka Shing Cheung and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 743–749, https://doi.org/10.1093/jnci/djx267
Reported Incidence and Survival of Fallopian Tube Carcinomas: A Population-Based Analysis From the North American Association of Central Cancer Registries
Britton Trabert and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 750–757, https://doi.org/10.1093/jnci/djx263
Colorectal Adenomas and Cancers After Childhood Cancer Treatment: A DCOG-LATER Record Linkage Study
Jop C Teepen and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 758–767, https://doi.org/10.1093/jnci/djx266
Immune Infiltration in Invasive Lobular Breast Cancer
Christine Desmedt and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 768–776, https://doi.org/10.1093/jnci/djx268
The Effect of Topoisomerase I Inhibitors on the Efficacy of T-Cell-Based Cancer Immunotherapy
Jodi A McKenzie and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 777–786, https://doi.org/10.1093/jnci/djx257
Brief Communications
Immune-Active Microenvironment in Small Cell Carcinoma of the Ovary, Hypercalcemic Type: Rationale for Immune Checkpoint Blockade
Petar Jelinic and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 787–790, https://doi.org/10.1093/jnci/djx277
The Future Burden of Colorectal Cancer Among US Blacks and Whites
Marzieh Araghi and others
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Pages 791–793, https://doi.org/10.1093/jnci/djx287
Corrigendum
Corrigendum to “Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial”
JNCI: Journal of the National Cancer Institute, Volume 110, Issue 7, July 2018, Page 794, https://doi.org/10.1093/jnci/djy096
Advertisement
Advertisement